home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

47 rows where docket_id = "FDA-2005-D-0211" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, last_modified, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 2

  • 2007 45
  • 2005 2

document_type 2

  • Supporting & Related Material 45
  • Notice 2

agency_id 1

  • FDA 47
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2005-D-0211-0050 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 FDA Notice NAD-Notice of Availability of Data 2007-10-29T04:00:00Z 2007 10 2007-10-26T04:00:00Z   2008-04-11T23:46:52Z   0 0 0900006480441500
FDA-2005-D-0211-0049 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Considerations for Plasmid DNA Vaccines for Infectious Disease Indications Supporting & Related Material Guidance 2007-10-29T04:00:00Z 2007 10     2020-05-14T14:43:32Z   0 0 09000064804414ff
FDA-2005-D-0211-0026 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414e6
FDA-2005-D-0211-0013 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414d3
FDA-2005-D-0211-0012 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414d2
FDA-2005-D-0211-0009 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:52Z   0 0 09000064804414cf
FDA-2005-D-0211-0034 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:52Z   0 0 09000064804414ee
FDA-2005-D-0211-0045 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:52Z   0 0 09000064804414fa
FDA-2005-D-0211-0019 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:52Z   0 0 09000064804414da
FDA-2005-D-0211-0044 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414f9
FDA-2005-D-0211-0032 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:52Z   0 0 09000064804414ec
FDA-2005-D-0211-0046 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:52Z   0 0 09000064804414fb
FDA-2005-D-0211-0025 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:52Z   0 0 09000064804414e4
FDA-2005-D-0211-0038 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414f2
FDA-2005-D-0211-0042 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:54Z   0 0 09000064804414f7
FDA-2005-D-0211-0008 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414ce
FDA-2005-D-0211-0006 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414cc
FDA-2005-D-0211-0015 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414d5
FDA-2005-D-0211-0022 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414e1
FDA-2005-D-0211-0028 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414e8
FDA-2005-D-0211-0047 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:54Z   0 0 09000064804414fd
FDA-2005-D-0211-0021 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:52Z   0 0 09000064804414dd
FDA-2005-D-0211-0017 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414d8
FDA-2005-D-0211-0014 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:54Z   0 0 09000064804414d4
FDA-2005-D-0211-0011 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414d1
FDA-2005-D-0211-0024 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414e3
FDA-2005-D-0211-0043 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414f8
FDA-2005-D-0211-0029 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:54Z   0 0 09000064804414e9
FDA-2005-D-0211-0037 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414f1
FDA-2005-D-0211-0048 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:54Z   0 0 09000064804414fe
FDA-2005-D-0211-0036 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414f0
FDA-2005-D-0211-0039 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:54Z   0 0 09000064804414f3
FDA-2005-D-0211-0031 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414eb
FDA-2005-D-0211-0010 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414d0
FDA-2005-D-0211-0023 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:54Z   0 0 09000064804414e2
FDA-2005-D-0211-0033 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:54Z   0 0 09000064804414ed
FDA-2005-D-0211-0020 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414db
FDA-2005-D-0211-0007 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414cd
FDA-2005-D-0211-0030 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:52Z   0 0 09000064804414ea
FDA-2005-D-0211-0018 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:54Z   0 0 09000064804414d9
FDA-2005-D-0211-0041 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:54Z   0 0 09000064804414f5
FDA-2005-D-0211-0040 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414f4
FDA-2005-D-0211-0016 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414d6
FDA-2005-D-0211-0035 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414ef
FDA-2005-D-0211-0027 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 Reference Supporting & Related Material REF-Reference (internal unless indicated) 2007-10-26T04:00:00Z 2007 10     2008-04-11T23:46:53Z   0 0 09000064804414e7
FDA-2005-D-0211-0002 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 GUIDANCE Supporting & Related Material GDL-Guidance 2005-03-01T05:00:00Z 2005 3     2008-04-11T23:46:52Z   0 0 090000648044146e
FDA-2005-D-0211-0001 FDA Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 FDA Notice NAD-Notice of Availability of Data 2005-03-01T05:00:00Z 2005 3 2005-02-18T05:00:00Z 2005-05-20T03:59:59Z 2008-04-11T23:46:52Z   0 0 0900006480441299

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 210.569ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API